(R)-2-(2-((R)-1-(tert-butoxycarbonylamino)-2-phenylethyl)thiazol-4-yl)-4-methyl-4,5-dihydrothiazole-4-carboxylic acid | 1315334-27-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (R)-2-(2-((R)-1-(tert-butoxycarbonylamino)-2-phenylethyl)thiazol-4-yl)-4-methyl-4,5-dihydrothiazole-4-carboxylic acid
• 英文别名: Boc-D-Phe-Tz-Tzin-OH；(4R)-4-methyl-2-[2-[(1R)-1-[(2-methylpropan-2-yl)oxycarbonylamino]-2-phenylethyl]-1,3-thiazol-4-yl]-5H-1,3-thiazole-4-carboxylic acid
• CAS: 1315334-27-0
• 化学式: C₂₁H₂₅N₃O₄S₂
• 分子量: 447.579
• InChiKey: YKWDHHMBSRMPMY-SZNDQCEHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  30
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  154
• 氢给体数：
  2
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  (R)-2-(2-((R)-1-(tert-butoxycarbonylamino)-2-phenylethyl)thiazol-4-yl)-4-methyl-4,5-dihydrothiazole-4-carboxylic acid 在 benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate 、 1-羟基苯并三唑 、 N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 、 三氟乙酸 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 生成
  参考文献：
  名称：

  Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability

  摘要：

  The total synthesis of largazole and four analogues is reported. All analogues were nanomolar HDAC inhibitors. The antiproliferative activity is driven by lipophilicity and cell permeability. In murine liver homogenates, largazole is rapidly metabolized (half-life <= 5 min) to the thiol which has a half-life of 51 min. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.02.024
• 作为产物：
  描述：

  (R)-methyl 2-(1-(tert-butoxycarbonylamino)-2-phenylethyl)thiazole-4-carboxylate 在 氨 、 碳酸氢钠 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 、 N,N-二异丙基乙胺 、 三氟乙酸酐 、 lithium hydroxide 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 甲醇 、 二氯甲烷 、 水 为溶剂， 反应 2.0h， 生成 (R)-2-(2-((R)-1-(tert-butoxycarbonylamino)-2-phenylethyl)thiazol-4-yl)-4-methyl-4,5-dihydrothiazole-4-carboxylic acid
  参考文献：
  名称：

  Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability

  摘要：

  The total synthesis of largazole and four analogues is reported. All analogues were nanomolar HDAC inhibitors. The antiproliferative activity is driven by lipophilicity and cell permeability. In murine liver homogenates, largazole is rapidly metabolized (half-life <= 5 min) to the thiol which has a half-life of 51 min. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2011.02.024

文献信息

• Synthesis of the Thiazole–Thiazoline Fragment of Largazole Analogues
  作者：Frederik Diness、Daniel S. Nielsen、David P. Fairlie

  DOI：10.1021/jo201675r

  日期：2011.12.2

  fragment of the marine natural product largazole, a potent histone deacetylase 1 inhibitor, has been synthesized in five steps. The methodology provides rapid access to thiazole-4-carbonitrile, thiazole-4-carbimidate, thiazole–oxazoline, and other thiazole–thiazoline derivatives that are important intermediates in the total synthesis of many natural products with important biological properties.

  海洋天然产物largazole（一种有效的组蛋白脱乙酰基酶1抑制剂）的噻唑-噻唑啉片段已通过五个步骤合成。该方法可以快速获得噻唑-4-腈，噻唑-4-氨基甲酸酯，噻唑-恶唑啉和其他噻唑-噻唑啉衍生物，它们是许多具有重要生物学特性的天然产物的总合成中的重要中间体。
• Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability
  作者：Hanae Benelkebir、Sabrina Marie、Annette L. Hayden、Jason Lyle、Paul M. Loadman、Simon J. Crabb、Graham Packham、A. Ganesan

  DOI：10.1016/j.bmc.2011.02.024

  日期：2011.6

  The total synthesis of largazole and four analogues is reported. All analogues were nanomolar HDAC inhibitors. The antiproliferative activity is driven by lipophilicity and cell permeability. In murine liver homogenates, largazole is rapidly metabolized (half-life <= 5 min) to the thiol which has a half-life of 51 min. (C) 2011 Elsevier Ltd. All rights reserved.